0001104659-17-002761.txt : 20170118 0001104659-17-002761.hdr.sgml : 20170118 20170118144759 ACCESSION NUMBER: 0001104659-17-002761 CONFORMED SUBMISSION TYPE: 13F-HR PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20161231 FILED AS OF DATE: 20170118 DATE AS OF CHANGE: 20170118 EFFECTIVENESS DATE: 20170118 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Versant Venture Management, LLC CENTRAL INDEX KEY: 0001560009 IRS NUMBER: 954767945 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 13F-HR SEC ACT: 1934 Act SEC FILE NUMBER: 028-16849 FILM NUMBER: 17533235 BUSINESS ADDRESS: STREET 1: ONE SANSOME STREET, SUITE 3630 CITY: SAN FRANCISCO STATE: CA ZIP: 94104 BUSINESS PHONE: 650-233-7877 MAIL ADDRESS: STREET 1: ONE SANSOME STREET, SUITE 3630 CITY: SAN FRANCISCO STATE: CA ZIP: 94104 13F-HR 1 primary_doc.xml 13F-HR LIVE 0001560009 XXXXXXXX 12-31-2016 12-31-2016 false Versant Venture Management, LLC

One Sansome Street, Suite 3630 San Francisco CA 94104

13F HOLDINGS REPORT 028-16849 N Robin L. Praeger 415-801-8100 /s/ Robin L. Praeger San Francisco CA 01-17-2017 0 7 102740818 false INFORMATION TABLE 2 a17-2690_1informationtable.xml INFORMATION TABLE Clovis Oncology, Inc. Common Stock 189464100 18097419 407416 SH OTR 0 407416 0 CymaBay Therapeutics, Inc. Common Stock 23257D103 1814080 1048601 SH OTR 0 1048601 0 Achaogen, Inc. Common Stock 004449104 16680599 1281152 SH OTR 0 1281152 0 Ocular Therapeutix, Inc. Common Stock 67576A100 18542764 2215384 SH OTR 0 2215384 0 Glaukos Corporation Common Stock 377322102 2449980 71428 SH OTR 0 71428 0 Audentes Therapeutics, Inc. Common Stock 05070R104 33010821 1806832 SH OTR 0 1806832 0 ImmuneDesign Corp. Common Stock 45252L103 12145155 2208210 SH OTR 0 2208210 0